"There is a need for pharmaceutical companies to build HCP relationships, backed by scientific credibility"

Docquity, headquartered in Singapore, is Southeast Asia's largest professional network for verified healthcare professionals (HCPs), connecting over 410,000 doctors across the region.

- Ayesha Siddiqui

Amit Vithal, Co-founder and Chief of Growth, Docquity, Singapore

The platform enables HCPs to share clinical experiences and engage in secure, peer-to-peer discussions. Docquity uses AI/ML to provide insights into HCP preferences, shaping personalized healthcare engagement strategies for enterprises. In an interview with BioSpectrum, Amit Vithal, Co-founder and Chief of Growth, Docquity discusses key trends in digital health across Asia, Docquity's expansion into government healthcare initiatives, how the company's data-driven approach is transforming healthcare engagement and shaping future B2G collaborations across Asia. Edited excerpts;

Tell us about how Docquity has influenced the healthcare landscape in Southeast Asia and how the company's data-driven approach differentiates it in the market?

As Southeast Asia's largest network of over 410,000 verified HCPs, Docquity gains profound insight into HCP needs and preferences, which we leverage to strengthen healthcare knowledge and interactions.

Guided by our vision to connect HCPs to build healthier lives around the world at scale, our platform and services empower our users, HCPs, to learn, connect, and grow across many use cases. For example, our comprehensive educational resources have delivered over 6 million Continuing Medical Education (CME) credits to doctors till date, reaching even those serving in remote communities. We're also fostering collaboration among HCPs to address complex health challenges in the region. Our platform allows them to easily consult their peers on unique cases, equipping them to provide more effective patient diagnoses and care.